Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block vs Infiltration for Pain in Pediatric Laparoscopic Cholecystectomy
NCT02712151Phase 3Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Mar 2024
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in postoperative pain, sponsored by Boston Children's Hospital. Planned start Mar 2024; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02712151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02712151.